Pay in 4 interest-free payments of $28.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Treatment of autologous CLL-T cell co-cultures with Lenalidomide reverses impaired CD8+ T cell lytic synapse formation and granzyme B trafficking
When serum-starved cells are treated with 10 % FBS in the presence of 7-methoxyisoflavone
local injection of the AMPA receptor agonist S-bromo-willardiine at day 5 after birth induced cortical damage and white matter damage
[Epub ahead of print] PubMed PMID: 25260842
HG-14-10-04 7 HCl MPS1/TTK Treatment of autologous CLL-T cellHG 14 10 04 is a novel potent and specific ALK inhibitor. Product information CAS Number: 1356962 34 9 Molecular Weight: 532. 08 Formula: C29H34ClN7O Chemical Name: 5 chloro 4 (1H indol 3 yl) N {2 methoxy 4 [4 (4 methylpiperazin 1 yl)piperidin 1 yl]phenyl}pyrimidin 2 amine Smiles: CN1CCN(CC1)C1CCN(CC1)C1=CC(OC)=C(C=C1)NC1=NC(=C(Cl)C=N1)C1=CNC2=CC=CC=C21 InChiKey: HRYNCLKDKCPYBF UHFFFAOYSA N InChi: InChI=1S C29H34ClN7O c1 35 13 15 37(16 14 35)20 9 11
US$ 1058.50
US$ 1704.50
US$ 371.50
US$ 412.50
US$ 1849.50
US$ 5196.00
US$ 236.50
US$ 151.50
US$ 554.00
US$ 866.00
US$ 2973.00
US$ 701.50
US$ 154.00
US$ 1484.50